Imidazo[1,2-a]pyrimidines as Functionally Selective and Orally Bioavailable GABAAα2/α3 Binding Site Agonists for the Treatment of Anxiety Disorders

Autor: C. Goodacre, Simon, J. Street, Leslie, J. Hallett, David, M. Crawforth, James, Kelly, Sarah, P. Owens, Andrew, P. Blackaby, Wesley, T. Lewis, Richard, Stanley, Joanna, J. Smith, Alison, Ferris, Pushpinder, Sohal, Bindi, M. Cook, Susan, Pike, Andrew, Brown, Nicola, A. Wafford, Keith, Marshall, George, L. Castro, José, R. Atack, John
Zdroj: Journal of Medicinal Chemistry; January 2006, Vol. 49 Issue: 1 p35-38, 4p
Abstrakt: A series of high-affinity GABAA agonists with good oral bioavailability in rat and dog and functional selectivity for the GABAAα2 and -α3 subtypes is reported. The 7-trifluoromethylimidazopyrimidine 14g and the 7-propan-2-olimidazopyrimidine 14k are anxiolytic in both conditioned and unconditioned animal models of anxiety with minimal sedation observed at full BZ binding site occupancy.
Databáze: Supplemental Index